Med Life SA

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: ROMEDLACNOR6
RON
6.89
-26.51 (-79.37%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Net Sales
2,715.57
2,210.44
1,795.43
1,427.22
1,077.45
967.38
794.56
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
2,715.57
2,210.44
1,795.43
1,427.22
1,077.45
967.38
794.56
Raw Material Cost
2,414.82
1,980.58
1,600.57
1,176.32
894.07
841.99
668.70
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
669.46
562.51
458.75
346.05
287.80
301.94
253.28
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
102.63
82.17
42.49
27.45
23.25
20.65
17.57
Selling and Distribution Expenses
159.82
134.42
111.59
82.78
58.29
71.90
94.26
Other Expenses
-77.21
-64.47
-50.12
-37.35
-30.94
-32.26
-27.08
Total Expenditure (Excl Depreciation)
2,574.64
2,115.01
1,712.16
1,259.10
954.02
913.90
762.96
Operating Profit (PBDIT) excl Other Income
140.9
95.39999999999999
83.3
168.1
123.4
53.5
31.6
Other Income
10.14
6.25
11.93
-3.15
-1.76
-7.71
9.80
Operating Profit (PBDIT)
398.06
285.89
247.62
278.73
224.57
136.25
98.38
Interest
102.63
82.17
42.49
27.45
23.25
20.65
17.57
Exceptional Items
-2.41
-4.67
-3.17
-2.10
-19.87
0.00
0.00
Gross Profit (PBDT)
300.76
229.85
194.87
250.90
183.38
125.39
125.87
Depreciation
253.94
194.75
152.41
113.76
102.90
90.48
56.98
Profit Before Tax
39.07
4.30
49.56
135.42
78.55
25.12
23.83
Tax
22.32
8.46
12.12
22.51
14.79
8.34
7.05
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
25.04
3.68
32.17
102.61
56.70
13.61
13.37
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
25.04
3.68
32.17
102.61
56.70
13.61
13.37
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-8.28
-7.85
5.26
10.30
7.06
3.17
3.41
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
16.75
-4.16
37.43
112.91
63.76
16.79
16.78
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.25
0.25
0.25
0.25
0.25
0.25
0.25
Reserves
432.63
415.29
416.78
338.11
241.27
184.15
159.35
Earnings per share (EPS)
0.05
0.01
0.06
0.19
0.11
0.0
0.03
Diluted Earnings per share
0.05
0.01
0.06
0.19
0.11
0.0
0.03
Operating Profit Margin (Excl OI)
4.93%
3.84%
4.64%
11.78%
11.46%
5.53%
3.98%
Gross Profit Margin
10.79%
9.0%
11.25%
17.46%
16.84%
11.95%
10.17%
PAT Margin
0.92%
0.17%
1.79%
7.19%
5.26%
1.41%
1.68%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2024 is 22.86% vs 23.11% in Dec 2023

stock-summary

Consolidate Net Profit

YoY Growth in year ended Dec 2024 is 500.00% vs -111.23% in Dec 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2024 is 38.73% vs 18.63% in Dec 2023

stock-summary

Interest

YoY Growth in year ended Dec 2024 is 24.82% vs 93.41% in Dec 2023

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2024 has improved from Dec 2023

Compare Annual Results Of Med Life SA With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(RON)
Change(%)
Net Sales
2,715.57
0
2,715.57
Other Operating Income
0.00
0.00
0.00
Total Operating income
2,715.57
0
2,715.57
Raw Material Cost
2,414.82
0
2,414.82
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
669.46
0
669.46
Power Cost
0
0
0.00
Manufacturing Expenses
102.63
0
102.63
Selling and Distribution Expenses
159.82
0
159.82
Other Expenses
-77.21
0.00
-77.21
Total Expenditure (Excl Depreciation)
2,574.64
0
2,574.64
Operating Profit (PBDIT) excl Other Income
140.93
0.00
140.93
Other Income
10.14
0
10.14
Operating Profit (PBDIT)
398.06
0
398.06
Interest
102.63
0
102.63
Exceptional Items
-2.41
0
-2.41
Gross Profit (PBDT)
300.76
0
300.76
Depreciation
253.94
0
253.94
Profit Before Tax
39.07
0
39.07
Tax
22.32
0
22.32
Provisions and contingencies
0
0
0.00
Profit After Tax
25.04
0
25.04
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
25.04
0
25.04
Share in Profit of Associates
0
0
0.00
Minority Interest
-8.28
0
-8.28
Other related items
0.00
0.00
0.00
Consolidated Net Profit
16.75
0
16.75
Equity Capital
0
0
0.00
Face Value
0.25
0
0.00
Reserves
432.63
0
432.63
Earnings per share (EPS)
0.05
0
0.05
Diluted Earnings per share
0.05
0
0.05
Operating Profit Margin (Excl OI)
4.93%
0%
0.00
4.93%
Gross Profit Margin
10.79%
0%
0.00
10.79%
PAT Margin
0.92%
0%
0.00
0.92%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 271.56 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 22.86% vs 23.11% in Dec 2023

Annual - Consolidate Net Profit
Consolidate Net Profit 1.68 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 500.00% vs -111.23% in Dec 2023

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 38.79 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 38.73% vs 18.63% in Dec 2023

Annual - Interest
Interest 10.26 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 24.82% vs 93.41% in Dec 2023

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 4.93%
in Dec 2024

Figures in %
stock-summary

YoY Growth in year ended Dec 2024 has improved from Dec 2023